Skip to main content
. 2018 Jan 3;20(4):898–909. doi: 10.1111/dom.13175

Figure 1.

Figure 1

Change in glycated haemoglobin (HbA1c) and weight assessed quarterly (Q1–Q4) in the first year following the initiation of injectable antihyperglycaemic treatment, comparing propensity score matched injectable‐naive exenatide once weekly (EQW) and basal insulin (BI) initiators, by age